Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.32
-0.08 (-1.48%)
Apr 29, 2026, 4:08 PM HKT

Lepu Biopharma Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Cash & Equivalents
853.03401.29426.02669.4155.17
Upgrade
Short-Term Investments
-11.088.788.8159.07
Upgrade
Trading Asset Securities
105.7363.6363.63--
Upgrade
Cash & Short-Term Investments
958.76475.99498.43678.2214.24
Upgrade
Cash Growth
101.42%-4.50%-26.51%216.57%-71.86%
Upgrade
Accounts Receivable
66.8845.8237.83.04-
Upgrade
Other Receivables
64.8335.9717.3722.30.07
Upgrade
Receivables
131.7181.7955.1725.340.07
Upgrade
Inventory
51.8322.7929.4124.0624.18
Upgrade
Prepaid Expenses
-63.8989.3681.6273.34
Upgrade
Other Current Assets
-1.054.783.582.3
Upgrade
Total Current Assets
1,142645.51677.15812.8314.13
Upgrade
Property, Plant & Equipment
1,0271,0511,0871,039978.44
Upgrade
Long-Term Investments
397.35114.07126.69122.39137.97
Upgrade
Goodwill
-52.6452.6452.6452.64
Upgrade
Other Intangible Assets
501.07382.61381.59398.18422.45
Upgrade
Other Long-Term Assets
31.5634.8259.01104.1176.43
Upgrade
Total Assets
3,1002,2812,3842,5292,082
Upgrade
Accounts Payable
183.83236.14207.61166.13158.82
Upgrade
Accrued Expenses
-34.4832.8832.5123.96
Upgrade
Short-Term Debt
---329.6340.41
Upgrade
Current Portion of Long-Term Debt
756.32538.41434.330.3620
Upgrade
Current Portion of Leases
26.2144.3628.3437.1722.91
Upgrade
Current Income Taxes Payable
-16.9111.511.94
Upgrade
Current Unearned Revenue
0.410.91--4
Upgrade
Other Current Liabilities
195.29172.31195.43246.49277.02
Upgrade
Total Current Liabilities
1,1621,044899.56843.79549.06
Upgrade
Long-Term Debt
275.55255.94260290.06232.47
Upgrade
Long-Term Leases
-11.4624.183.0919.48
Upgrade
Long-Term Unearned Revenue
17.6618.02121212
Upgrade
Long-Term Deferred Tax Liabilities
37.6937.6937.6937.6937.69
Upgrade
Other Long-Term Liabilities
243.92232.27262.17441.79384.29
Upgrade
Total Liabilities
1,7371,5991,4961,6281,235
Upgrade
Common Stock
1,8041,7111,6591,6591,532
Upgrade
Additional Paid-In Capital
-2,5782,4202,4201,842
Upgrade
Retained Earnings
-2,504-2,765-2,354-2,331-1,642
Upgrade
Comprehensive Income & Other
2,086-820.49-828.8-847.04-894.2
Upgrade
Total Common Equity
1,386702.83896.91900.76836.71
Upgrade
Minority Interest
-23.5-21.02-8.21-10.37
Upgrade
Shareholders' Equity
1,363681.8888.7900.76847.08
Upgrade
Total Liabilities & Equity
3,1002,2812,3842,5292,082
Upgrade
Total Debt
1,058850.16746.82690.3335.26
Upgrade
Net Cash (Debt)
-99.32-374.17-248.4-12.1-121.03
Upgrade
Net Cash Per Share
-0.06-0.22-0.15-0.01-0.08
Upgrade
Filing Date Shares Outstanding
1,8041,7111,6591,6591,659
Upgrade
Total Common Shares Outstanding
1,8041,7111,6591,6591,532
Upgrade
Working Capital
-19.77-398.01-222.42-30.99-234.93
Upgrade
Book Value Per Share
0.770.410.540.540.55
Upgrade
Tangible Book Value
885.23267.58462.68449.95361.62
Upgrade
Tangible Book Value Per Share
0.490.160.280.270.24
Upgrade
Buildings
-660.2345.5545.55-
Upgrade
Machinery
-378.64365.38246.16195.06
Upgrade
Construction In Progress
-22.38628.15661.64633.35
Upgrade
Leasehold Improvements
-118.91106.03105.71102.42
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.